gms | German Medical Science

information platform

Germany, Land of Ideas

Deutsche Initiative für Netzwerkinformation (DINI, German Initiative for Network Information)

Your initial contact to the requested addressee


Here you can get in touch with the recipient specified below.

All indicated mandatory fields () have to be completed.
Using this functionality for commercial advertising is prohibited.

Recipient: Gudrun Fleischhack
Article: Results of a Phase II trial of h-R3 monoclonal antibody (Nimotuzumab) in the treatment of resistant or relapsed high-grade gliomas in children and adolescents
27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocOP416 (OP416)